RAPT
RAPT Therapeutics Inc
NASDAQ: RAPT · HEALTHCARE · BIOTECHNOLOGY
$58.02
+0.00% today
Updated 2026-03-04
Market cap
$1.68B
P/E ratio
—
P/S ratio
411.22x
EPS (TTM)
$-11.66
Dividend yield
—
52W range
$6 – $58
Volume
3.2M
RAPT Therapeutics Inc (RAPT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-27.12M | $-32.95M | $-35.47M | $-40.49M | $-61.03M | $-70.77M | $-97.05M | $-83.30M |
| Capital expenditures | $1.12M | $3.50M | $888000.00 | $398000.00 | $755000.00 | $845000.00 | $1.13M | $122000.00 |
| Depreciation | $1.38M | $1.24M | $1.33M | $1.12M | $996000.00 | $1.05M | $3.55M | $1.20M |
| Stock-based comp | $716000.00 | $1.17M | $2.05M | $8.69M | $9.95M | $11.26M | $17.09M | $19.93M |
| Free cash flow | $-28.25M | $-36.45M | $-36.36M | $-40.89M | $-61.78M | $-71.62M | $-98.17M | $-83.42M |
| Investing cash flow | $-1.12M | $-3.50M | $-843000.00 | $-87.44M | $-81.35M | $-45.49M | $104.13M | $52.70M |
| Financing cash flow | $30.10M | $52.73M | $49.90M | $75.46M | $141.48M | $131.18M | $1.45M | $152.85M |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-52.47M | $-891000.00 | $14.92M | — | — |